Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 101.9 USD 0.75%
Market Cap: 150.7B USD

During the last 3 months Boston Scientific Corp insiders have not bought any shares, and sold 27.9m USD worth of shares. The stock price has dropped by 0% over this period (open performance analysis).

The last transaction was made on Apr 21, 2025 by Brown Vance R (Chairman of the Board and Chief Executive Officer) , who sold 458.9k USD worth of BSX shares.

Last Transactions:
Brown Vance R
Chairman of the Board and Chief Executive Officer
$-458.9k
Mahoney Michael F
Chairman and CEO
$-16.4m
Brown Vance R
Chairman of the Board and Chief Executive Officer
$-486.7k
Woodworth Emily
$-50.4k
Woodworth Emily
Vice President, Talent Management
$-999.9k
Mirviss Jeffrey B.
Executive Vice President and President, Peripheral Interventions
$-279.6k
Zane Ellen M
Director
$-1.4m
Brown Vance R
Chairman of the Board and Chief Executive Officer
$-505k
Mirviss Jeffrey B.
Executive Vice President and President, Peripheral Interventions
$-159.1k
Sorenson John Bradley
Chairman of the Board
$-277.4k
Brennan Daniel J.
Executive Vice President, General Counsel and Corporate Secretary
$-301.8k
Sorenson John Bradley
Chairman of the Board
$-127.7k
Sorenson John Bradley
Chairman of the Board
$-671.2k
Brennan Daniel J.
Executive Vice President, General Counsel and Corporate Secretary
$-1.6m
Mirviss Jeffrey B.
Executive Vice President and President, Peripheral Interventions
$-1.4m
Ludwig Edward J
Senior Vice President, General Counsel & Secretary
$-1.3m
Sorenson John Bradley
Chairman of the Board
$-685.2k
Butcher Arthur C
Executive Vice President and Group President, MedSurg and President, Endoscopy
$-863.2k
Mirviss Jeffrey B.
Executive Vice President and President, Peripheral Interventions
$-642.7k
Brennan Daniel J.
Executive Vice President, General Counsel and Corporate Secretary
$-870.6k
Sorenson John Bradley
Chairman of the Board
$-370.8k
Carruthers Wendy
Senior Vice President, Human Resources
$-633.9k
Woodworth Emily
Vice President, Talent Management
$-121.1k
Butcher Arthur C
Executive Vice President and Group President, MedSurg and President, Endoscopy
$-1.3m
Carruthers Wendy
Senior Vice President, Human Resources
$-588.9k
Fitzgerald Joseph Michael
EVP & Group President, Cardiology
$-11.3m
Mahoney Michael F
Chairman and CEO
$-6.8m
Carruthers Wendy
Senior Vice President, Human Resources
$-585.6k
Mahoney Michael F
Chairman and CEO
$-13.2m
Carruthers Wendy
Senior Vice President, Human Resources
$-570.5k
Fitzgerald Joseph Michael
EVP & Group President, Cardiology
$-1.1m
Butcher Arthur C
Executive Vice President and Group President, MedSurg and President, Endoscopy
$-1.1m
View All Transactions

During the last 3 months Boston Scientific Corp insiders have not bought any shares, and sold 27.9m USD worth of shares. The stock price has dropped by 0% over this period (open performance analysis).

The last transaction was made on Apr 21, 2025 by Brown Vance R (Chairman of the Board and Chief Executive Officer) , who sold 458.9k USD worth of BSX shares.

Sold
0-3
months
27.9m USD
9
3-6
months
4.5m USD
6
6-9
months
35.2m USD
4
9-12
months
16.2m USD
8
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Boston Scientific Corp
Insider Trading Chart

Boston Scientific Corp
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Boston Scientific Corp
Last Insider Transactions

Global
Insiders Monitor

Boston Scientific Corp
Glance View

Economic Moat
Narrow
Market Cap
150.3B USD
Industry
Health Care

In the world of medical devices, Boston Scientific Corp. has carved out a significant niche, navigating the intersection of innovation and healthcare with precision. Founded in 1979, the company has built a robust reputation for developing a diverse range of products that address complex medical conditions. Boston Scientific operates through various segments, primarily focusing on interventional medical specialties that target areas such as cardiology, endoscopy, and neuromodulation. Through its relentless pursuit of innovation, the company continues to push boundaries, enhancing the diagnostic and therapeutic capabilities of physicians worldwide. The heartbeat of its operations lies in its extensive research and development endeavors, where cutting-edge technology meets advanced medical knowledge to produce life-enhancing solutions. At its core, Boston Scientific makes money by designing, manufacturing, and selling medical devices used in minimally invasive procedures. Its product portfolio includes solutions for coronary artery disease, heart rhythm disorders, peripheral artery disease, and many other critical ailments. By partnering with healthcare providers, Boston Scientific enables hospitals and clinics to offer high-quality, efficient care that caters to patient needs in a cost-effective manner. Revenue streams flow through direct sales channels and strategic partnerships across global markets, reflecting a combination of organic growth and strategic acquisitions. Moreover, the company actively reinvests in future technologies, ensuring its position as a pioneer in medical advancements while meeting the ever-evolving demands of the industry.

BSX Intrinsic Value
69.61 USD
Overvaluation 32%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top